DermaDetect

AI-driven Digital Diagnostics for Skin Disorders

Health Tech & Life Sciences
Active
Seed Rehovot Founded 2016
Total raised
$4.4M
Last: Seed 2022-03
Stage
Seed
Founded
2016
Headcount
8
HQ
Rehovot
Sector
Health Tech & Life Sciences

About

DermaDetect is an AI-driven software that enables remote diagnosis and treatment of skin disorders. Based on intelligent software, the platform integrates easily with existing systems, is easy to use and accessible 24/7, and has an attractive pay-per-usage pricing model. This skin diagnostics capability can be seamlessly integrated into any dermatological disciplines that require skin diagnostics. In addition to DermaDetect, the company has launched DermaAssess and DermaManage, which are based on the same technology, and is currently developing additional products. The company is rolling out its automated skin diagnosis application across the entire Maccabi Health Services network in Israel. DermaDetect's FDA/CE-cleared platform serves more than 2.5 million patients while empowering physicians by augmenting the current clinical workflow and helping them manage the ever-increasing workload without compromising quality of care.

Funding history · 4 rounds · $4.4M total

2022-03
Seed $1.9M
2021-10
Seed $450K
2021-03
Equity crowdfunding $330K
2017-11
Pre-Seed $815K

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is DermaDetect's core technology and its primary application?
DermaDetect utilizes AI-driven software for the remote diagnosis and treatment of skin disorders. Its platform integrates easily with existing systems and is accessible 24/7.
When was DermaDetect founded and where is its headquarters located?
DermaDetect was founded in November 2016 and is headquartered in Rehovot, Israel.
Which Israeli healthcare provider is rolling out DermaDetect's automated skin diagnosis application?
DermaDetect is rolling out its automated skin diagnosis application across the entire Maccabi Health Services network in Israel.
What is the total amount of funding DermaDetect has raised?
DermaDetect has raised a total of $4,352,200 in funding.
Which investors participated in DermaDetect's Seed round in March 2022?
In March 2022, DermaDetect raised a Seed round with participation from Keren Maccabi and Medison Ventures.
What are some of the other products DermaDetect has launched based on its core technology?
In addition to DermaDetect, the company has launched DermaAssess and DermaManage, which are based on the same technology.
What is the employee count for DermaDetect?
DermaDetect has 8 employees.
What certifications does DermaDetect's platform hold?
DermaDetect's platform is FDA/CE-cleared.
When did DermaDetect receive grants from the IIA and what were the amounts?
DermaDetect received a grant of $571,500 from the IIA in November 2021 and another grant of $285,700 from the IIA in December 2022.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Artificial IntelligenceDeep LearningComputer VisionMachine LearningPlatforms & InterfacesSoftwareMobile
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2BB2C

Highlights

1 PatentsVerified

Tags

digital-healthcaretelemedicinenon-invasiveactionable-insightsdecision-makingdeep-learningmachine-learningdata-analyticsmobile-applicationsdiagnosticsmhealthmedical-devicesartificial-intelligenceskin-caredermatologycomputer-visionhealthcare-providershospitalsmedical-technologiestreatmentshome-caredoctorsoptronics